Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, and Vaxart, Inc. (OTCQX: VXRT), a clinical-stage ...

About 1 in 4 American adults got a covid vaccine shot during the 2024-25 virus season, a fraction health care experts warn ...

India's top drug regulator cited insufficient evidence of efficacy in the two studies conducted by Serum Institute and ICMR.

Illinois lawmakers passed two-dozen bills during their annual fall veto session including a measure about vaccine guidelines ...

An alleged extortion attempt, a petty yearslong grudge, shocking social media posts, and ominous text messages make up the ...

Despite the muted success of Sanofi's Dengvaxia in the global market, Globaldata analysts forecast a rosy outlook for Qdenga.

Natasha Smith has seen her views on vaccines transform. “I had been reading books about pregnancy and parenthood of toddlers, ...

Through his leadership at the FDA's Center for Biologics Evaluation and Research (CBER), Vinay Prasad, MD, MPH has pushed out at least 7 senior leaders and created an environment that employees worry ...

Moffett, MD, is a professor and division chief of pediatric infectious diseases at West Virginia University School of ...

The Peter Kim Lab was recently awarded $18 million by the Coalition for Epidemic Preparedness to create a vaccine to protect ...

Dr. Vinay Prasad, who oversees FDA’s vaccine and biologics center, resigned in July after coming under fire from conservative ...

New and changing FDA and CDC guidance on COVID-19 vaccine eligibility has left many confused. Here's what to know about getting the shot this fall.